Marijuana Plant Extract Reduces Epileptic Seizures by Half
GW Pharmaceuticals Plcs cannabidiol, made from the non-psychoactive portion of a marijuana plant, cut by half the seizures suffered by epilepsy patients in an expanded access program that didnt use a placebo.
The experience of 213 hard-to-treat patients age 2 to 42, including some who were already taking a dozen drugs to fend off seizures, is a promising start for the strawberry-flavored liquid extract, which may be a potent new therapy for the condition, said lead researcher Orrin Devinsky, director of the New York University Langone Comprehensive Epilepsy Center. The findings released Monday are scheduled to be presented at the American Academy of Neurologys annual meeting on April 22 in Washington.
GW Pharma is seeking regulatory approval for the therapy to treat patients with severe forms of epilepsy and expects to present results from mandated studies by early 2016, said Chief Executive Officer Justin Gover. Epidiolex, as the oil is known, is being compared with a placebo to affirm its safety and effectiveness.
For this group that has failed multiple medications, the response is quite positive, Devinsky said. Over time its certainly the hope that this would replace other therapies, if studies that use comparison groups are successful.
more
http://www.bloomberg.com/news/articles/2015-04-13/marijuana-extract-from-gw-pharma-cuts-epileptic-seizures-by-half?cmpid=yhoo